BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 11682785)

  • 1. NRTI-associated mitochondrial toxicity.
    Landovitz RJ; Sax PE
    AIDS Clin Care; 2001 May; 13(5):43-5, 48-9, 52. PubMed ID: 11682785
    [No Abstract]   [Full Text] [Related]  

  • 2. Evidence for mitochondrial toxicity: lactic acidosis as proof of concept.
    Brinkman K
    J HIV Ther; 2001 Mar; 6(1):13-6. PubMed ID: 11501196
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical manifestations of mitochondrial toxicity.
    Walker UA
    J HIV Ther; 2001 Mar; 6(1):17-21. PubMed ID: 11501197
    [No Abstract]   [Full Text] [Related]  

  • 4. Update on mitochondrial toxicity of antiretrovirals and its link to lipodystrophy.
    McComsey G
    AIDS Rev; 2002; 4(3):140-7. PubMed ID: 12416448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondrial toxicity and lactic acidosis.
    Proj Inf Perspect; 2000 Mar; (29):10-1. PubMed ID: 12772662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nucleoside analogues toxicities related to mitochondrial dysfunction: focus on HIV-infected children.
    Viganò A; Giacomet V
    Antivir Ther; 2005; 10 Suppl 2():M53-64. PubMed ID: 16152706
    [No Abstract]   [Full Text] [Related]  

  • 7. Long-term complications of nucleoside reverse transcriptase inhibitor therapy.
    Dieterich DT
    AIDS Read; 2003 Apr; 13(4):176-84, 187. PubMed ID: 12741368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondrial toxicity.
    Scoular A
    J HIV Ther; 2001 Mar; 6(1):1-3. PubMed ID: 11501195
    [No Abstract]   [Full Text] [Related]  

  • 9. Highly active antiretroviral therapy (HAART)-associated lactic acidosis: in vitro effects of combination of nucleoside analogues and protease inhibitors on mitochondrial function and lactic acid production.
    Nerurkar PV; Pearson L; Frank JE; Yanagihara R; Nerurkar VR
    Cell Mol Biol (Noisy-le-grand); 2003 Dec; 49(8):1205-11. PubMed ID: 14983988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Impact of reverse transcriptase inhibitors on sperm mitochondrial and genomic DNA in assisted reproduction techniques].
    Sergerie M; Martinet S; Kiffer N; Teulé R; Pasquier C; Bujan L
    Gynecol Obstet Fertil; 2004 Oct; 32(10):841-9. PubMed ID: 15501159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperlactataemia in HIV-infected patients: the role of NRTI-treatment.
    Vrouenraets SM; Treskes M; Regez RM; Troost N; Smulders YM; Weigel HM; Frissen PH; Brinkman K
    Antivir Ther; 2002 Dec; 7(4):239-44. PubMed ID: 12553477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The latest word on lipodystrophy and mitochondrial toxicity (and old words that still resound).
    Mascolini M
    IAPAC Mon; 2002 Jan; 8(1):14-32. PubMed ID: 11858198
    [No Abstract]   [Full Text] [Related]  

  • 13. NRTI-related mitochondrial toxicity in an HIV-infected woman.
    Jenny-Avital ER
    AIDS Clin Care; 2003 Oct; 15(10):87-9. PubMed ID: 14666921
    [No Abstract]   [Full Text] [Related]  

  • 14. Cell culture models for the investigation of NRTI-induced mitochondrial toxicity. Relevance for the prediction of clinical toxicity.
    Höschele D
    Toxicol In Vitro; 2006 Aug; 20(5):535-46. PubMed ID: 16406476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipodystrophy--introduction.
    TreatmentUpdate; 2001; 13(7):2-3. PubMed ID: 11794857
    [No Abstract]   [Full Text] [Related]  

  • 16. High doses of riboflavin and thiamine may help in secondary prevention of hyperlactatemia.
    McComsey GA; Lederman MM
    AIDS Read; 2002 May; 12(5):222-4. PubMed ID: 12061328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polyphenotypic expression of mitochondrial toxicity caused by nucleoside reverse transcriptase inhibitors.
    Miller RF; Shahmonesh M; Hanna MG; Unwin RJ; Schapira AH; Weller IV
    Antivir Ther; 2003 Jun; 8(3):253-7. PubMed ID: 12924544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Of power plants and energy shortages.
    TreatmentUpdate; 2001 May; 13(1):3-4. PubMed ID: 11570256
    [No Abstract]   [Full Text] [Related]  

  • 19. Risk factors for lactic acidosis in HIV-infected patients treated with nucleoside reverse-transcriptase inhibitors: a case-control study.
    Bonnet F; Bonarek M; Morlat P; Mercié P; Dupon M; Gemain MC; Malvy D; Bernard N; Pellegrin JL; Beylot J
    Clin Infect Dis; 2003 May; 36(10):1324-8. PubMed ID: 12746780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The case against Zerit.
    Huff B
    GMHC Treat Issues; 2002 Oct; 16(10):1-4. PubMed ID: 12458548
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.